scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1572-0241.2000.03369.X |
P8608 | Fatcat ID | release_2s3h2eq3sve4zbvmmv7ha4tdfy |
P698 | PubMed publication ID | 11151887 |
P5875 | ResearchGate publication ID | 12177367 |
P2093 | author name string | Zucoloto S | |
Zago MA | |||
Martinelli AL | |||
Roselino AM | |||
Filho AB | |||
Villanova MG | |||
Franco RF | |||
Tavella MH | |||
Ramalho LN | |||
Secaf M | |||
P2860 | cites work | A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis | Q24310146 |
A population-based study of the clinical expression of the hemochromatosis gene | Q33872904 | ||
Classification of chronic hepatitis: diagnosis, grading and staging | Q40755087 | ||
The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients | Q42987489 | ||
Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America | Q42988426 | ||
Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection? | Q42997486 | ||
Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany | Q43037028 | ||
HCV infection in porphyria cutanea tarda | Q43038848 | ||
Abnormal uroporphyrin levels in chronic hepatitis C virus infection | Q45745702 | ||
Is hepatitis C virus infection a trigger of porphyria cutanea tarda? | Q45787026 | ||
Hereditary hemochromatosis: gene discovery and its implications for population-based screening | Q47820475 | ||
Mutation analysis in hereditary hemochromatosis | Q48067239 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Hepatitis C virus | Q708693 |
porphyria cutanea tarda | Q1479497 | ||
P304 | page(s) | 3516-3521 | |
P577 | publication date | 2000-12-01 | |
P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
P1476 | title | Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection | |
P478 | volume | 95 |
Q33712331 | Associations among behavior-related susceptibility factors in porphyria cutanea tarda |
Q62607272 | Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda |
Q50560311 | Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy. |
Q39894712 | Clinical outcomes in a prospective study of community-acquired hepatitis C virus infection in Northern Norway |
Q38164825 | Cutaneous porphyrias part I: epidemiology, pathogenesis, presentation, diagnosis, and histopathology |
Q36177897 | HFE gene in primary and secondary hepatic iron overload. |
Q44460264 | Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients |
Q81437099 | Hepatic iron quantitation and its relationship with disease measures and histologically assessed iron content |
Q34268811 | Hepatitis C, porphyria cutanea tarda and liver iron: an update |
Q35753723 | Host genetic determinants in hepatitis C virus infection |
Q42990376 | Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study |
Q43001698 | Porphyria cutanea tarda in the HFE-gene and hepatitis C virus era. |
Q91227989 | Porphyria cutanea tarda: Recent update |
Q37141723 | Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients |
Q35217843 | Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. |
Q36142859 | The D519G Polymorphism of Glyceronephosphate O-Acyltransferase Is a Risk Factor for Familial Porphyria Cutanea Tarda. |
Q43522902 | The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection |
Q83887878 | [Porphyria cutanea tarda and hemochromatosis in Spain] |
Search more.